APO Research
Talk to an analyst

APO RESEARCH · REPORT

Influenza A Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Influenza A Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025193 pages

Choose your research edition.

Industry ResearchInfluenza A Vaccine Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Influenza A Vaccine Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Influenza A Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Influenza A Vaccine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Influenza A Vaccine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Influenza A Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Influenza A Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Influenza A Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Influenza A Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Influenza A Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Influenza A Vaccine include Changsheng Bio-Technology, Abbott, Sanofi, Novartis, Merck, Sinovac Biotech, Hualan Biological Engineering, GSK and Beijing Tiantan Bio-Products, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Influenza A Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Influenza A Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Influenza A Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Influenza A Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Influenza A Vaccine Segment by Company

Changsheng Bio-Technology

Abbott

Sanofi

Novartis

Merck

Sinovac Biotech

Hualan Biological Engineering

GSK

Beijing Tiantan Bio-Products

Mitsubishi Tanabe Pharma

Medimmune

Influenza A Vaccine Segment by Type

Intramuscular Vaccine

Nasal Spray Vaccine

Influenza A Vaccine Segment by Application

3-18 Years Old

Above 18 Years Old

Influenza A Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Influenza A Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Influenza A Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Influenza A Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Influenza A Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Influenza A Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Influenza A Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Influenza A Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Influenza A Vaccine Industry Trends Table 2. Influenza A Vaccine Industry Drivers Table 3. Influenza A Vaccine Industry Opportunities and Challenges Table 4. Influenza A Vaccine Industry Restraints Table 5. Global Influenza A Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Influenza A Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Influenza A Vaccine Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Influenza A Vaccine Sales Market Share by Manufacturers Table 9. Global Influenza A Vaccine Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Influenza A Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Influenza A Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Influenza A Vaccine Manufacturers, Product Type & Application Table 13. Global Influenza A Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Influenza A Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Intramuscular Vaccine Table 17. Major Manufacturers of Nasal Spray Vaccine Table 18. Global Influenza A Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Influenza A Vaccine Sales by Type (2021-2026) & (k units) Table 20. Global Influenza A Vaccine Sales by Type (2027-2032) & (k units) Table 21. Global Influenza A Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Influenza A Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Influenza A Vaccine Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Influenza A Vaccine Revenue by Type (2021-2026) & (k units) Table 25. Global Influenza A Vaccine Revenue by Type (2027-2032) & (k units) Table 26. Global Influenza A Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Influenza A Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of 3-18 Years Old Table 29. Major Manufacturers of Above 18 Years Old Table 30. Global Influenza A Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 31. Global Influenza A Vaccine Sales by Application (2021-2026) & (k units) Table 32. Global Influenza A Vaccine Sales by Application (2027-2032) & (k units) Table 33. Global Influenza A Vaccine Sales Market Share by Application (2021-2026) Table 34. Global Influenza A Vaccine Sales Market Share by Application (2027-2032) Table 35. Global Influenza A Vaccine Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Influenza A Vaccine Revenue by Application (2021-2026) & (k units) Table 37. Global Influenza A Vaccine Revenue by Application (2027-2032) & (k units) Table 38. Global Influenza A Vaccine Revenue Market Share by Application (2021-2026) Table 39. Global Influenza A Vaccine Revenue Market Share by Application (2027-2032) Table 40. Global Influenza A Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 41. Global Influenza A Vaccine Sales by Region (2021-2026) & (k units) Table 42. Global Influenza A Vaccine Sales Market Share by Region (2021-2026) Table 43. Global Influenza A Vaccine Sales Forecasted by Region (2027-2032) & (k units) Table 44. Global Influenza A Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Influenza A Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 46. North America Influenza A Vaccine Sales by Country (2021-2026) & (k units) Table 47. North America Influenza A Vaccine Sales by Country (2027-2032) & (k units) Table 48. Europe Influenza A Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. Europe Influenza A Vaccine Sales by Country (2021-2026) & (k units) Table 50. Europe Influenza A Vaccine Sales by Country (2027-2032) & (k units) Table 51. Asia Pacific Influenza A Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Asia Pacific Influenza A Vaccine Sales by Country (2021-2026) & (k units) Table 53. Asia Pacific Influenza A Vaccine Sales by Country (2027-2032) & (k units) Table 54. South America, Middle East and Africa Influenza A Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. South America, Middle East and Africa Influenza A Vaccine Sales by Country (2021-2026) & (k units) Table 56. South America, Middle East and Africa Influenza A Vaccine Sales by Country (2027-2032) & (k units) Table 57. Global Influenza A Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Influenza A Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Influenza A Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Influenza A Vaccine Revenue Market Share by Region (2021-2026) Table 61. Global Influenza A Vaccine Revenue Market Share by Region (2027-2032) Table 62. Changsheng Bio-Technology Company Information Table 63. Changsheng Bio-Technology Business Overview Table 64. Changsheng Bio-Technology Influenza A Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Changsheng Bio-Technology Influenza A Vaccine Product Portfolio Table 66. Changsheng Bio-Technology Recent Development Table 67. Abbott Company Information Table 68. Abbott Business Overview Table 69. Abbott Influenza A Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Abbott Influenza A Vaccine Product Portfolio Table 71. Abbott Recent Development Table 72. Sanofi Company Information Table 73. Sanofi Business Overview Table 74. Sanofi Influenza A Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Sanofi Influenza A Vaccine Product Portfolio Table 76. Sanofi Recent Development Table 77. Novartis Company Information Table 78. Novartis Business Overview Table 79. Novartis Influenza A Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Novartis Influenza A Vaccine Product Portfolio Table 81. Novartis Recent Development Table 82. Merck Company Information Table 83. Merck Business Overview Table 84. Merck Influenza A Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Merck Influenza A Vaccine Product Portfolio Table 86. Merck Recent Development Table 87. Sinovac Biotech Company Information Table 88. Sinovac Biotech Business Overview Table 89. Sinovac Biotech Influenza A Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Sinovac Biotech Influenza A Vaccine Product Portfolio Table 91. Sinovac Biotech Recent Development Table 92. Hualan Biological Engineering Company Information Table 93. Hualan Biological Engineering Business Overview Table 94. Hualan Biological Engineering Influenza A Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Hualan Biological Engineering Influenza A Vaccine Product Portfolio Table 96. Hualan Biological Engineering Recent Development Table 97. GSK Company Information Table 98. GSK Business Overview Table 99. GSK Influenza A Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. GSK Influenza A Vaccine Product Portfolio Table 101. GSK Recent Development Table 102. Beijing Tiantan Bio-Products Company Information Table 103. Beijing Tiantan Bio-Products Business Overview Table 104. Beijing Tiantan Bio-Products Influenza A Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Beijing Tiantan Bio-Products Influenza A Vaccine Product Portfolio Table 106. Beijing Tiantan Bio-Products Recent Development Table 107. Mitsubishi Tanabe Pharma Company Information Table 108. Mitsubishi Tanabe Pharma Business Overview Table 109. Mitsubishi Tanabe Pharma Influenza A Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Mitsubishi Tanabe Pharma Influenza A Vaccine Product Portfolio Table 111. Mitsubishi Tanabe Pharma Recent Development Table 112. Medimmune Company Information Table 113. Medimmune Business Overview Table 114. Medimmune Influenza A Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Medimmune Influenza A Vaccine Product Portfolio Table 116. Medimmune Recent Development Table 117. Key Raw Materials Table 118. Raw Materials Key Suppliers Table 119. Influenza A Vaccine Distributors List Table 120. Influenza A Vaccine Customers List Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Influenza A Vaccine Product Image Figure 2. Global Influenza A Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Influenza A Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Influenza A Vaccine Sales (2021-2032) & (k units) Figure 5. Global Influenza A Vaccine Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Influenza A Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Intramuscular Vaccine Image Figure 9. Nasal Spray Vaccine Image Figure 10. Global Influenza A Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Influenza A Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Influenza A Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Influenza A Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Influenza A Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Influenza A Vaccine Revenue Market Share by Type (2021-2032) Figure 16. 3-18 Years Old Image Figure 17. Above 18 Years Old Image Figure 18. Global Influenza A Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Influenza A Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Influenza A Vaccine Sales Market Share by Application (2021-2032) Figure 21. Global Influenza A Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Influenza A Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Influenza A Vaccine Revenue Market Share by Application (2021-2032) Figure 24. North America Influenza A Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 25. North America Influenza A Vaccine Sales Market Share by Country (2021-2032) Figure 26. U.S. Influenza A Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 27. Canada Influenza A Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 28. Mexico Influenza A Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 29. Europe Influenza A Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Influenza A Vaccine Sales Market Share by Country (2021-2032) Figure 31. Germany Influenza A Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 32. France Influenza A Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 33. U.K. Influenza A Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 34. Italy Influenza A Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 35. Netherlands Influenza A Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 36. Asia Pacific Influenza A Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Influenza A Vaccine Sales Market Share by Country (2021-2032) Figure 38. China Influenza A Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 39. Japan Influenza A Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 40. South Korea Influenza A Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 41. Southeast Asia Influenza A Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 42. India Influenza A Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 43. Australia Influenza A Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 44. South America, Middle East and Africa Influenza A Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Influenza A Vaccine Sales Market Share by Country (2021-2032) Figure 46. Brazil Influenza A Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Africa Influenza A Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 48. Saudi Arabia Influenza A Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 49. Turkey Influenza A Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 50. Argentina Influenza A Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 51. UAE Influenza A Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 52. Egypt Influenza A Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 53. Chile Influenza A Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 54. Global Influenza A Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Influenza A Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Influenza A Vaccine Revenue (2021-2032) & (US$ Million) Figure 57. North America Influenza A Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Influenza A Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. Europe Influenza A Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Influenza A Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Influenza A Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Influenza A Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Influenza A Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Influenza A Vaccine Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Influenza A Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Intramuscular Vaccine
  • Nasal Spray Vaccine
Applications
  • 3-18 Years Old
  • Above 18 Years Old
Companies covered
  • Changsheng Bio-Technology
  • Abbott
  • Sanofi
  • Novartis
  • Merck
  • Sinovac Biotech
  • Hualan Biological Engineering
  • GSK
  • Beijing Tiantan Bio-Products
  • Mitsubishi Tanabe Pharma
  • Medimmune

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Influenza A Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Influenza A Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Influenza A Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Influenza A Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Influenza A Vaccine Market Dynamics
  1. 2.1 Influenza A Vaccine Industry Trends
  2. 2.2 Influenza A Vaccine Industry Drivers
  3. 2.3 Influenza A Vaccine Industry Opportunities and Challenges
  4. 2.4 Influenza A Vaccine Industry Restraints
3 Influenza A Vaccine Market by Manufacturers
  1. 3.1 Global Influenza A Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Influenza A Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Influenza A Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Influenza A Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Influenza A Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Influenza A Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Influenza A Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Influenza A Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Influenza A Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Influenza A Vaccine Tier 1, Tier 2, and Tier 3
4 Influenza A Vaccine Market by Type
  1. 4.1 Influenza A Vaccine Type Introduction
  2. 4.1.1 Intramuscular Vaccine
  3. 4.1.2 Nasal Spray Vaccine
  4. 4.2 Global Influenza A Vaccine Sales by Type
  5. 4.2.1 Global Influenza A Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Influenza A Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Influenza A Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Influenza A Vaccine Revenue by Type
  9. 4.3.1 Global Influenza A Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Influenza A Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Influenza A Vaccine Revenue Market Share by Type (2021-2032)
5 Influenza A Vaccine Market by Application
  1. 5.1 Influenza A Vaccine Application Introduction
  2. 5.1.1 3-18 Years Old
  3. 5.1.2 Above 18 Years Old
  4. 5.2 Global Influenza A Vaccine Sales by Application
  5. 5.2.1 Global Influenza A Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Influenza A Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global Influenza A Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Influenza A Vaccine Revenue by Application
  9. 5.3.1 Global Influenza A Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Influenza A Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global Influenza A Vaccine Revenue Market Share by Application (2021-2032)
6 Global Influenza A Vaccine Sales by Region
  1. 6.1 Global Influenza A Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Influenza A Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Influenza A Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Influenza A Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Influenza A Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Influenza A Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Influenza A Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Influenza A Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Influenza A Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Influenza A Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Influenza A Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Influenza A Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Influenza A Vaccine Revenue by Region
  1. 7.1 Global Influenza A Vaccine Revenue by Region
  2. 7.1.1 Global Influenza A Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Influenza A Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Influenza A Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Influenza A Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Influenza A Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Influenza A Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Influenza A Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Influenza A Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Influenza A Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Influenza A Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Influenza A Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Influenza A Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Changsheng Bio-Technology
  2. 8.1.1 Changsheng Bio-Technology Company Information
  3. 8.1.2 Changsheng Bio-Technology Business Overview
  4. 8.1.3 Changsheng Bio-Technology Influenza A Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Changsheng Bio-Technology Influenza A Vaccine Product Portfolio
  6. 8.1.5 Changsheng Bio-Technology Recent Developments
  7. 8.2 Abbott
  8. 8.2.1 Abbott Company Information
  9. 8.2.2 Abbott Business Overview
  10. 8.2.3 Abbott Influenza A Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Abbott Influenza A Vaccine Product Portfolio
  12. 8.2.5 Abbott Recent Developments
  13. 8.3 Sanofi
  14. 8.3.1 Sanofi Company Information
  15. 8.3.2 Sanofi Business Overview
  16. 8.3.3 Sanofi Influenza A Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Influenza A Vaccine Product Portfolio
  18. 8.3.5 Sanofi Recent Developments
  19. 8.4 Novartis
  20. 8.4.1 Novartis Company Information
  21. 8.4.2 Novartis Business Overview
  22. 8.4.3 Novartis Influenza A Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Novartis Influenza A Vaccine Product Portfolio
  24. 8.4.5 Novartis Recent Developments
  25. 8.5 Merck
  26. 8.5.1 Merck Company Information
  27. 8.5.2 Merck Business Overview
  28. 8.5.3 Merck Influenza A Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Merck Influenza A Vaccine Product Portfolio
  30. 8.5.5 Merck Recent Developments
  31. 8.6 Sinovac Biotech
  32. 8.6.1 Sinovac Biotech Company Information
  33. 8.6.2 Sinovac Biotech Business Overview
  34. 8.6.3 Sinovac Biotech Influenza A Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sinovac Biotech Influenza A Vaccine Product Portfolio
  36. 8.6.5 Sinovac Biotech Recent Developments
  37. 8.7 Hualan Biological Engineering
  38. 8.7.1 Hualan Biological Engineering Company Information
  39. 8.7.2 Hualan Biological Engineering Business Overview
  40. 8.7.3 Hualan Biological Engineering Influenza A Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Hualan Biological Engineering Influenza A Vaccine Product Portfolio
  42. 8.7.5 Hualan Biological Engineering Recent Developments
  43. 8.8 GSK
  44. 8.8.1 GSK Company Information
  45. 8.8.2 GSK Business Overview
  46. 8.8.3 GSK Influenza A Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 GSK Influenza A Vaccine Product Portfolio
  48. 8.8.5 GSK Recent Developments
  49. 8.9 Beijing Tiantan Bio-Products
  50. 8.9.1 Beijing Tiantan Bio-Products Company Information
  51. 8.9.2 Beijing Tiantan Bio-Products Business Overview
  52. 8.9.3 Beijing Tiantan Bio-Products Influenza A Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Beijing Tiantan Bio-Products Influenza A Vaccine Product Portfolio
  54. 8.9.5 Beijing Tiantan Bio-Products Recent Developments
  55. 8.10 Mitsubishi Tanabe Pharma
  56. 8.10.1 Mitsubishi Tanabe Pharma Company Information
  57. 8.10.2 Mitsubishi Tanabe Pharma Business Overview
  58. 8.10.3 Mitsubishi Tanabe Pharma Influenza A Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Mitsubishi Tanabe Pharma Influenza A Vaccine Product Portfolio
  60. 8.10.5 Mitsubishi Tanabe Pharma Recent Developments
  61. 8.11 Medimmune
  62. 8.11.1 Medimmune Company Information
  63. 8.11.2 Medimmune Business Overview
  64. 8.11.3 Medimmune Influenza A Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Medimmune Influenza A Vaccine Product Portfolio
  66. 8.11.5 Medimmune Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Influenza A Vaccine Value Chain Analysis
  2. 9.1.1 Influenza A Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Influenza A Vaccine Production Mode & Process
  6. 9.2 Influenza A Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Influenza A Vaccine Distributors
  9. 9.2.3 Influenza A Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst